PMC:7172841 / 1511-1599 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T18","span":{"begin":2,"end":9},"obj":"Body_part"},{"id":"T19","span":{"begin":5,"end":9},"obj":"Body_part"}],"attributes":[{"id":"A18","pred":"fma_id","subj":"T18","obj":"http://purl.org/sig/ont/fma/fma63147"},{"id":"A19","pred":"fma_id","subj":"T19","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"d NK cell cytopenias are characteristics of severe COVID-19\n• IL-6 blocker Tocilizumab "}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T21","span":{"begin":51,"end":59},"obj":"Disease"}],"attributes":[{"id":"A21","pred":"mondo_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"d NK cell cytopenias are characteristics of severe COVID-19\n• IL-6 blocker Tocilizumab "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T17","span":{"begin":2,"end":9},"obj":"http://purl.obolibrary.org/obo/CL_0000623"}],"text":"d NK cell cytopenias are characteristics of severe COVID-19\n• IL-6 blocker Tocilizumab "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T13","span":{"begin":63,"end":65},"obj":"Chemical"}],"attributes":[{"id":"A13","pred":"chebi_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A14","pred":"chebi_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"}],"text":"d NK cell cytopenias are characteristics of severe COVID-19\n• IL-6 blocker Tocilizumab "}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T53","span":{"begin":51,"end":59},"obj":"SP_7"},{"id":"T54","span":{"begin":63,"end":67},"obj":"PR:000001393"},{"id":"T55","span":{"begin":76,"end":87},"obj":"DG_35"},{"id":"T91561","span":{"begin":51,"end":59},"obj":"SP_7"},{"id":"T288","span":{"begin":63,"end":67},"obj":"PR:000001393"},{"id":"T45776","span":{"begin":76,"end":87},"obj":"DG_35"}],"text":"d NK cell cytopenias are characteristics of severe COVID-19\n• IL-6 blocker Tocilizumab "}

{"project":"LitCovid-PubTator","denotations":[{"id":"80","span":{"begin":2,"end":20},"obj":"Disease"},{"id":"81","span":{"begin":51,"end":59},"obj":"Disease"},{"id":"85","span":{"begin":63,"end":67},"obj":"Gene"},{"id":"87","span":{"begin":76,"end":87},"obj":"Chemical"}],"attributes":[{"id":"A80","pred":"tao:has_database_id","subj":"80","obj":"MESH:D054066"},{"id":"A81","pred":"tao:has_database_id","subj":"81","obj":"MESH:C000657245"},{"id":"A85","pred":"tao:has_database_id","subj":"85","obj":"Gene:3569"},{"id":"A87","pred":"tao:has_database_id","subj":"87","obj":"MESH:C502936"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"d NK cell cytopenias are characteristics of severe COVID-19\n• IL-6 blocker Tocilizumab "}